Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials. Leuk Res 2021 11;110:106714

Date

10/02/2021

Pubmed ID

34598075

DOI

10.1016/j.leukres.2021.106714

Scopus ID

2-s2.0-85115920018

Author List

Yarlagadda N, Gundarlapalli S, Sharma S, Suelzer E, Abid MB, Abdallah AO, Schinke C, Atrash S, Mohan M

Author

Muhammad Bilal Abid MD Assistant Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

ADP-ribosyl Cyclase 1
Antibodies, Monoclonal
Communicable Diseases
Hematologic Diseases
Humans
Multiple Myeloma
Prognosis
Randomized Controlled Trials as Topic